Detailed View
TXG - 10x Genomics, Inc.
Latest filing: 2026-03-31 | Reporting: gaap
Market Cap
5,471,811,584
Adj EBIT (TTM)
-38,703,000
Enterprise Value
5,471,811,584
Last Price
43.10
Earnings Yield
-0.71%
Return on Capital
-4.62%
Capital
837,740,000
1Y Price Chart
Last Price: -
1Y Change: -
Company Summary
Loading summary...
| endDate | formType | fiscalYear | Revenue | OperatingIncomeLoss |
|---|---|---|---|---|
| 2026-03-31 | 10-Q | 2026 | 150,843,000 | -17,046,000 |
| 2025-12-31 | 10-K (Q4 derived) | 2025 | 166,030,000 | -19,541,000 |
| 2025-09-30 | 10-Q | 2025 | 149,002,000 | -32,242,000 |
| 2025-06-30 | 10-Q | 2025 | 172,908,000 | 30,126,000 |
| 2025-03-31 | 10-Q | 2025 | 154,883,000 | -39,328,000 |
| 2024-12-31 | 10-K (Q4 derived) | 2024 | 165,021,000 | -49,839,000 |
| 2024-09-30 | 10-Q | 2024 | 151,654,000 | -41,485,000 |
| 2024-06-30 | 10-Q | 2024 | 153,104,000 | -41,737,000 |
Notice something wrong?
Submit a quick report with a snapshot of the values you are seeing.